FSD2 antibody (AA 221-320) (HRP)

Catalog No. ABIN1712288

Product Details anti-FSD2 Antibody (HRP)

Target: FSD2 (Fibronectin Type III and SPRY Domain Containing 2 (FSD2))

Binding Specificity: AA 221-320

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This FSD2 antibody is conjugated to HRP

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Predicted Reactivity: Human,Mouse,Rat,Dog,Cow,Sheep,Pig

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human FSD2

Isotype: IgG

Application Details

Application Notes: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for FSD2

Target: FSD2 (Fibronectin Type III and SPRY Domain Containing 2 (FSD2))

Alternative Name: FSD2 (FSD2 Products)

Synonyms: SPRYD1 antibody, 9830160G03Rik antibody, Spryd1 antibody, RGD1305167 antibody, fibronectin type III and SPRY domain containing 2 antibody, FSD2 antibody, Fsd2 antibody

Background:

Synonyms: Fibronectin type III and SPRY domain containing 2, Fibronectin type III and SPRY domain containing protein 2, RP11-127F21, SPRY domain containing 1, SPRY domain containing protein 1, SPRYD1,

Background: FSD2 is a 749 amino acid protein containing one B30.2/SPRY domain and two fibronectin type-III domains. The gene encoding FSD2 maps to human chromosome 15q25.2. Encoding more than 700 genes, chromosome 15 is made up of approximately 106 million base pairs and consists of about 3 % of the human genome. Angelman and Prader-Willi syndromes are associated with loss of function or deletion of genes in the 15q11-q13 region. In the case of Angelman syndrome, this loss is due to inactivity of the maternal 15q11-q13 encoded UBE3A gene in the brain by either chromosomal deletion or mutation. Prader-Willi syndrome, Tay-Sachs disease and Marfan syndrome are also associated with chromosome 15.

Gene ID: 123722